Abstract
Background
Streptococcal infection and basal ganglia inflammation are hypothesized to be involved in Tourette’s syndrome (TS). There is a need for effective therapies for managing TS. We studied streptococcal infection and immunity in TS following immunomodulator (pidotimod) therapy.
Methods
Blood samples from 58 patients with TS and 128 age-matched healthy controls enabled measurement of antistreptolysin O (ASO), T cells, natural killer (NK) cells, interleukin-6 (IL-6) and interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α). Forty-four patients with abnormal T cell numbers were divided into two groups and treated with pidotimod granules (pidotimod group, n = 20) or pidotimod plus dopaminergic receptor antagonists (combination group, n = 24). Yale Global Tic Severity Scale (YGTSS) scores and immunologic indices were assessed after treatment.
Results
An ASO >1:200 was found in 22.4 % of children with TS, 7.5 % of controls, and 38.9 % of children with both TS and attention deficit hyperactivity disorder (ADHD) compared to 15.0 % of children with TS alone (P < 0.05). Children with TS showed decreased CD3+ and CD4+ T cells, CD4+/CD8+ ratio, IL-6 and IL-8, increased NKC and TNF-α (P < 0.05) as compared to controls. ASO-positive children with TS had lower CD4+ T cells as compared to ASO-negative children with TS, and lower IL-6 and IL-8 levels as compared to controls (P < 0.05). After 8 weeks of pidotimod treatment, IL-8 was increased compared to either tiapride hydrochloride or haloperidol and pidotimod (P < 0.05).
Conclusions
Streptococcal infection in TS patients is associated with immune and cytokine dysfunction, which can be potentially managed with immunomodulator therapy.

References
Bitsko RH, Holbrook JR, Visser SN, Mink JW, Zinner SH, Ghandour RM, Blumberg SJ (2014) A national profile of Tourette syndrome, 2011–2012. J Dev Behav Pediatr 35:317–322
Ali F, Morrison KE, Cavanna AE (2013) The complex genetics of Gilles de la Tourette syndrome: implications for clinical practice. Neuropsychiatry 3:321–330
Bloch M, State M, Pittenger C (2011) Recent advances in Tourette syndrome. Curr Opin Neurol 24:119–125
Egan CA, Marakovitz SE, O’Rourke JA, Osiecki L, Illmann C, Barton L, McLaughlin E, Proujansky R, Royal J, Cowley H, Rangel-Lugo M, Pauls DL, Scharf JM, Mathews CA (2012) Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies. Am J Med Genet B Neuropsychiatr Genet 159B:987–996
Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM (2003) Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74:602–607
Kansy JW, Katsovich L, McIver KS, Pick J, Zabriskie JB, Lombroso PJ, Leckman JF, Bibb JA (2006) Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 181:165–176
Madhusudan N, Cavanna AE (2013) The role of immune dysfunction in the development of tics and susceptibility to infections in Tourette syndrome: a systematic review. Basal Ganglia 3:77–84
Kirvan CA, Swedo SE, Kurahara D, Cunningham MW (2006) Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s chorea. Autoimmunity 39:21–29
Hoekstra PJ, Dietrich A, Edwards MJ, Elamin I, Martino D (2013) Environmental factors in Tourette syndrome. Neurosci Biobehav Rev 37:1040–1049
Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Dow S, Zamkoff J, Dubbert BK, Lougee L (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. AJ Psychiatry 155:264–271
Pavone P, Parano E, Rizzo R, Trifiletti RR (2006) Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants. J Child Neurol 21:727–736
Murphy TK, Kurlan R, Leckman J (2010) The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 20:317–331
Kawikova I, Leckman JF, Kronig H, Katsovich L, Bessen DE, Ghebremichael M, Bothwell AL (2007) Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry 61:273–278
Rizzo R, Gulisano M, Pavone P, Fogliani F, Robertson MM (2006) Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol 21:747–753
Martino D, Chiarotti F, Buttiglione M, Cardona F, Creti R, Nardocci N, Orefici G, Veneselli E, Rizzo R (2011) The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort. Dev Med Child Neurol 53:951–957
Morris CM, Pardo-Villamizar C, Gause CD, Singer HS (2009) Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 276:45–48
Yeh CB, Wu CH, Tsung HC, Chen CW, Shyu JF, Leckman JF (2006) Antineural antibody in patients with Tourette’s syndrome and their family members. J Biomed Sci 13:101–112
Morer A, Vinas O, Lazaro L, Bosch J, Toro J, Castro J (2005) D8/17 monoclonal antibody: an unclear neuropsychiatric marker. Behav Neurol 16:1–8
Morshed SA, Parveen S, Leckman JF, Mercadante MT, Bittencourt Kiss MH, Miguel EC, Arman A, Yazgan Y, Fujii T, Paul S (2001) Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette’s syndrome, Sydenham’s chorea, and autoimmune disorders. Biol Psychiatry 50:566–577
Loiselle CR, Wendlandt JT, Rohde CA, Singer HS (2003) Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatr Neurol 28:119–125
Brilot F, Merheb V, Ding A, Murphy T, Dale RC (2011) Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 76:1508–1513
Murphy TK, Goodman WK, Fudge MW, Williams RC Jr, Ayoub EM, Dalal M, Lewis MH, Zabriskie JB (1997) B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette’s syndrome? AJ Psychiatry 154:402–407
Dale RC (2005) Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol 47:785–791
Singer HS, Hong JJ, Yoon DY, Williams PN (2005) Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 65:1701–1707
Weisz JL, McMahon WM, Moore JC, Augustine NH, Bohnsack JF, Bale JF, Johnson MB, Morgan JF, Jensen J, Tani LY, Veasy LG, Hill HR (2004) D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette’s disorder. Clin Diagn Lab Immunol 11:330–336
Yiyan R, Erzhen L, Chian C (2007) Monitor and analysis of streptococcal infection and immune function in children with Tourette syndrome. Chin J Pract Pediatr 22:183–186
Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (2008) Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression. Arch Pharm Res 31:1153–1159
Frances A, Mack AH, Ross R, First MB (2000) The DSM-IV classification and psychopharmacology. http://www.acnp.org/G4/GN401000082/CH081.html. Accessed 1 May 2012
Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989) The Yale global Tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566–573
Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9:914–920
Bombaci M, Grifantini R, Mora M, Reguzzi V, Petracca R, Meoni E, Balloni S, Zingaretti C, Falugi F, Manetti AG, Margarit I, Musser JM, Cardona F, Orefici G, Grandi G, Bensi G (2009) Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens. PLoS One 4:e6332
Cardona F, Orefici G (2001) Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 138:71–75
Müller N, Riedel M, Straube A, Günther W, Wilske B (2000) Increased anti-streptococcal antibodies in patients with Tourette’s syndrome. Psychiatry Res 94:43–49
Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA (2005) Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome. Biol Psychiatry 57:667–673
Gold R, Linker RA, Chan A (2007) Termination of inflammation in the nervous system. Rev Neurol (Paris) 163:672–676
Wang Y, Tang X, Yu B, Gu Y, Yuan Y, Yao D, Ding F, Gu X (2012) Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves. PLoS One 7:e43436
Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92:9328–9332
Pickering M, Cumiskey D, O’Connor JJ (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90:663–670
Mukhatyar V, Pai B, Clements I, Srinivasan A, Huber R, Mehta A, Mukhopadaya S, Rudra S, Patel G, Karumbaiah L, Bellamkonda R (2014) Molecular sequelae of topographically guided peripheral nerve repair. Ann Biomed Eng 42:1436–1455
Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997) TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483–490
Parrado A, Canellada A, Gentile T, Rey-Roldán E (2012) Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes. Neuroimmunomodulation 19:359–366
Acknowledgments
This study was supported by grant from program of the Capital Applied Research with Clinical Characteristics (D101100050010040). We are grateful to all patients in the Capital Institute of Pediatrics neurological department. We would like to acknowledge assistance from all staff of the neurology department of the Capital Institute of Pediatrics. We thank all participants and their family members for their cooperation in providing both clinical information and samples for the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Erzhen Li and Yiyan Ruan contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, E., Ruan, Y., Chen, Q. et al. Streptococcal infection and immune response in children with Tourette’s syndrome. Childs Nerv Syst 31, 1157–1163 (2015). https://doi.org/10.1007/s00381-015-2692-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-015-2692-8